Resource usage in outpatient care and reimbursement for cystic fibrosis in Germany
| Autor: | Daniela Eidt-Koch, J.-Matthias Graf von der Schulenburg, Thomas O. F. Wagner, A. Reimann, Thomas Mittendorf |
|---|---|
| Rok vydání: | 2010 |
| Předmět: |
Pulmonary and Respiratory Medicine
medicine.medical_specialty Resource (biology) business.industry Total cost 030503 health policy & services medicine.disease Cystic fibrosis 3. Good health Surgery 03 medical and health sciences 0302 clinical medicine Ambulatory care Cost driver 030225 pediatrics Pediatrics Perinatology and Child Health Emergency medicine Ambulatory Remuneration Medicine 0305 other medical science business Reimbursement |
| Zdroj: | Pediatric Pulmonology. 46:278-285 |
| ISSN: | 8755-6863 |
| Popis: | Objective Objective of this study is to assess and evaluate resource use in outpatient treatment in Germany and to compare it with remuneration. Methods Outpatient treatment was evaluated in seven different centers for pediatric and adult CF patients. Data were recorded during one representative month in 2006. A micro-costing approach was used to value resource use data. Results For outpatient treatment mean costs (excluding drugs) of 488€ per patient per quarter occurred. Correlation analyses identified significant cost drivers including age and co-morbidities (pancreatic insufficiency, hepatobiliary complications, lung function capacity, or bacterial lung colonization). Remuneration covered only 51% of the total costs (252€ per patient/quarter). Conclusions As the human resources available to these centers today are already below the requirements set by the European consensus for standards of CF care it will be important for a high level of patient care to reach a cost-covering remuneration scheme. Pediatr Pulmonol. 2011; 46:278–285. © 2011 Wiley-Liss, Inc. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|
Plný text